NEWS
ALIGN TECHNOLOGY INTRODUCES NEW SOFTWARE TO ACCELERATE DIGITAL PRACTICE TRANSFORMATION
Align Technology , a leading global medical device company that designs , manufactures and sells the Invisalign system of clear aligners , iTero intraoral scanners and exocad CAD / CAM software for digital orthodontics and restorative dentistry , has introduced new software innovations to accelerate digital practice transformation .
The Align Oral Health Suite is an intuitive and visually engaging digital interface designed to enhance dental consultations and drive dental treatment acceptance . It offers a modern approach to dental examinations , featuring an innovative clinical framework that empowers doctors and their clinic staff to conduct comprehensive oral health assessments via a single scan using patient-friendly terminology , and providing a highly engaging patient-centric experience .
Available on the iTero Element Plus Series , the Align Oral Health Suite covers a broad range of dental health conditions necessary for patients to better understand their oral health and enables doctors to create and share a custom oral health report , capturing the treatment recommendations discussed during the patient consultation .
Sreelakshmi Kolli , Align Technology Executive Vice President and Chief Digital Officer , said : “ AI-driven oral health assessment tools , like X-Ray Insights , discern data and enhance doctor-patient conversations , treatment option evaluation , and shared decision-making regarding oral health conditions and dental treatment options .
“ It goes beyond digital orthodontics and supports oral health assessments by generating a digital image of oral health findings , improving patient communication and helping increase practice growth .”
LILIUMX REBRANDS AS VALINK THERAPEUTICS AFTER SECURING US $ 7.8 MILLION INVESTMENT
LiliumX , an innovative BioTech start-up focused on the development of next-generation antibody-based therapeutics , has unveiled its new brand name , and welcomed three top industry leaders to the business , after securing US $ 7.8 million in investment .
Established in 2021 by Co-founders Arne Scheu and Irsyad Khairil , following their research into ‘ LEGO ’ protein technologies when studying at the
University of Oxford , LiliumX was initially founded to develop a rapid modular platform that enables the fast and efficient construction of better antibodybased drugs , such as bispecific antibodydrug conjugates ( bispecific ADCs ).
Dr Arne Scheu , Co-founder and CEO of Valink Therapeutics , said : “ Valink Therapeutics started with a vision to find truly novel drugs , combining features to build and screen drug candidates that could treat cancer in synergistic and even unexpected ways . We are now excited to release a modular platform that seamlessly combines multivalency , multispecificity , and drug conjugation , while rebranding as Valink Therapeutics to signify the extension beyond bispecificity alone , by Valency and Linking of small molecules into antibody-drug conjugates . We are delighted to enter this next stage of development with the support of our investors , Innovate UK , and new appointments Alex Lugovskoy ( NED ) and Jose Munoz-Olaya ( CSO ).”
www . intelligenthealth . tech 7